Article Details
Retrieved on: 2018-08-11 01:48:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Jazz Pharmaceuticals (NASDAQ:JAZZ)'s <b>stock</b> had its “buy” rating restated by Seaport Global <b>Securities</b> in a research report issued on Thursday.</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here